AVITA Medical (RCEL) Cash from Operations Growth (3y) (2022 - 2025)
AVITA Medical (RCEL) Cash from Operations Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 0.50% |
| 10 | AVITA Medical | 133.45 Mn | 117.11 Mn | 14.31 Mn | -40.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40.85% |
| Mar 31, 2025 | -3.23% |
| Sep 30, 2024 | 18.09% |
| Jun 30, 2024 | -0.64% |
| Mar 31, 2024 | -34.68% |
| Dec 31, 2023 | -24.16% |
| Sep 30, 2023 | -5.18% |
| Mar 31, 2023 | -7.54% |
| Dec 31, 2022 | 51.41% |